At the news
? BEARISHIMPACT 6/10 8-K filed Jun 24, 2026 at 16:01 ET
Indaptus Therapeutics raised approximately $12 million through a private placement of 20 million shares at $0.60 per share to non-U.S. accredited investors, representing ~17.7% dilution relative to the ~113.2 million shares outstanding. Proceeds are earmarked for working capital, clinical development, and general corporate purposes, with registration rights granted for resale.
- 20,000,000 shares sold at $0.60/share for ~$12M gross proceeds
- Dilution of ~17.7% based on ~113.2M shares outstanding pre-offering
- Shares sold to non-U.S. accredited investors under Regulation S
- Company granted registration rights for resale; filing due within 90 days of closing
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access